Chemical & Biological Treatment is a £62m revenue sub-group of RSE which combined five acquisitions in recent years. The business is pioneering a shift in "selling product" to "hiring assets" to address market needs and maximise profit.
Learn how a shift in approach is yielding high returns and how to navigate customer resistance to change.